chr2-48738464-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000233.4(LHCGR):​c.162-7166A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.196 in 152,072 control chromosomes in the GnomAD database, including 5,005 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 5005 hom., cov: 32)

Consequence

LHCGR
NM_000233.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.116

Publications

2 publications found
Variant links:
Genes affected
LHCGR (HGNC:6585): (luteinizing hormone/choriogonadotropin receptor) This gene encodes the receptor for both luteinizing hormone and choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia. [provided by RefSeq, Jul 2008]
STON1-GTF2A1L (HGNC:30651): (STON1-GTF2A1L readthrough) STON1-GTF2A1L mRNAs are infrequent but naturally occurring read-through products of the neighboring STON1 and GTF2A1L genes. These transcripts encode fusion proteins composed of the vast majority of each of the individual elements, stonin 1 and general transcription factor IIA, 1-like. Alternative splicing results in multiple transcript variants. The significance of these read-through variants and the function of the resulting protein products have not yet been determined. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.433 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000233.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LHCGR
NM_000233.4
MANE Select
c.162-7166A>G
intron
N/ANP_000224.2P22888-1
STON1-GTF2A1L
NM_001198593.2
c.3442-37816T>C
intron
N/ANP_001185522.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LHCGR
ENST00000294954.12
TSL:1 MANE Select
c.162-7166A>G
intron
N/AENSP00000294954.6P22888-1
ENSG00000279956
ENST00000602369.3
TSL:5
n.162-7166A>G
intron
N/AENSP00000473498.1R4GN57
STON1-GTF2A1L
ENST00000402114.6
TSL:2
c.3442-37816T>C
intron
N/AENSP00000385701.1

Frequencies

GnomAD3 genomes
AF:
0.196
AC:
29713
AN:
151954
Hom.:
4993
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.439
Gnomad AMI
AF:
0.156
Gnomad AMR
AF:
0.191
Gnomad ASJ
AF:
0.0608
Gnomad EAS
AF:
0.267
Gnomad SAS
AF:
0.191
Gnomad FIN
AF:
0.132
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0626
Gnomad OTH
AF:
0.163
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.196
AC:
29759
AN:
152072
Hom.:
5005
Cov.:
32
AF XY:
0.200
AC XY:
14882
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.438
AC:
18163
AN:
41434
American (AMR)
AF:
0.191
AC:
2919
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0608
AC:
211
AN:
3468
East Asian (EAS)
AF:
0.268
AC:
1382
AN:
5162
South Asian (SAS)
AF:
0.191
AC:
921
AN:
4810
European-Finnish (FIN)
AF:
0.132
AC:
1394
AN:
10578
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0626
AC:
4256
AN:
68006
Other (OTH)
AF:
0.164
AC:
347
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1002
2003
3005
4006
5008
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.101
Hom.:
766
Bravo
AF:
0.211
Asia WGS
AF:
0.227
AC:
789
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
4.3
DANN
Benign
0.78
PhyloP100
-0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6732721; hg19: chr2-48965603; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.